HIGHLIGHTS
- who: Enos Moyo et al. from the Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare POBox MP167, ZimbabweSchool of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa have published the research work: Long-Acting Injectable Drugs for HIV-1 Pre-Exposure Prophylaxis: Considerations for Africa, in the Journal: (JOURNAL)
- what: Although oral PrEP is an effective strategy to reduce the risk of HIV-1 transmission, its effectiveness is highly dependent on users adhering to the drugs.
- future: In the on-demand option if sexual activity continues a single . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.